Proceeds from the Series B financing will support the advancement of ILiAD’s next generation pertussis vaccine candidate, BPZE1. Inducing both systemic and mucosal immunity, BPZE1 is a live attenuated ...
ABP News on MSN
Protecting the liver and Ayurveda: Discover how evidence based medicines save your life
Rheumatoid Arthritis Treatment: Two main aspects are considered important in the development of new medicines – Efficacy and ...
Rheumatoid Arthritis: Arthritis, also known as Rheumatoid Arthritis, is an autoimmune disease that primarily affects the ...
ILiAD Biotechnologies has closed an oversubscribed $115 million series B fundraise to support the company’s next-generation ...
Sleep disorders are associated with significantly higher odds of rheumatoid arthritis (RA) among adults in the United States, according to results of a nationally representative, ...
For lower-risk patients undergoing coronary artery bypass grafting (CABG) for multivessel disease, radial artery plus one ...
IMVT-1402 potentially registrational trial in difficult-to-treat rheumatoid arthritis (D2T RA) fully enrolled, with topline data expected in the ...
Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...
Several commonly prescribed RA drugs can be self-injected at home, often using either a prefilled syringe or an auto-injector ...
Rheumatoid Arthritis Awareness Day is observed on February 2 each year. The Rheumatoid Patient Foundation started this day to ...
Mirador Therapeutics has raised $250M to advance clinical trials. Read about the Series B financing led by T. Rowe Price and ...
An implantable vagus nerve stimulation device yielded an ACR20 response rate of more than 52% at 12 months in patients with rheumatoid arthritis, according to findings published in Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results